International Journal of Clinical Pharmacy

Article	Citations
ESCP International Workshop: Pharmacotherapy challenges in the developing years: from conception to adolescence 24–25 April 2024, Bratislava, Slovakia	63
Bacillus coagulans TBC169 probiotics for intestinal function recovery after gynecological open surgery: a randomized, double-blind, placebo-controlled trial	59
Comment on: “whether temporal discounting is domain‑specific between health outcomes and money—a systematic review and meta‑analysis”	50
Implementation status of safety measures to prevent errors with non-oncologic methotrexate: surveys in community and hospital pharmacies	37
Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study	37
A systematic review of quantitative studies exploring staff views on antipsychotic use in residents with dementia in care homes	33
Cost-effectiveness analysis of fruquintinib in Chinese patients with refractory metastatic colorectal cancer	31
Characterising pharmacists’ interventions in chronic non-cancer pain care: a scoping review	27
Parents’ perspectives towards paediatric confectionary masked medications: a qualitative study	27
Global trends in pharmacovigilance-related events: a 30-year analysis from the 2019 global burden of disease study	27
Non-cardiovascular medication and readmission for heart failure: an observational cohort study	27
Efficacy and safety of metformin compared to insulin in gestational diabetes: a systematic review and meta-analysis of Chinese randomized controlled trials	26
Drug-induced liver injury associated with lopinavir-ritonavir in patients with COVID-19: a disproportionality analysis of U.S. food and drug administration adverse event reporting system (FAERS) data	26
Response to comment on 'Perioperative esketamine combined with butorphanol versus butorphanol alone for pain management following video-assisted lobectomy: a randomized controlled trial'	24
Variation in vancomycin dosing and therapeutic drug monitoring practices in neonatal intensive care units	23
Clinical pharmacist consultant in primary care settings in Slovenia focused on elderly patients on polypharmacy: successful national program from development to reimbursement	23
A 5-year trend in the use of sodium-glucose co-transporter 2 inhibitors and other oral antidiabetic drugs in a Middle Eastern country	23
Development and evaluation of an assessment of the age-appropriateness/inappropriateness of formulations used in children	23
Attitudes of non-participating general practitioners and community pharmacists towards interprofessional medication management in primary care: an interview study	22
Descriptive analysis of reported adverse events associated with anti-obesity medications using FDA Adverse Event Reporting System (FAERS) databases 2013–2020	22
Impact of intra-patient variability of tacrolimus on allograft function and CD4 + /CD8 + ratio in kidney transplant recipients: a retrospective single-center study	21
Identification of novel signal of proton pump inhibitor-associated drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis	21
Medication regimen complexity index and rehabilitation outcomes in post-acute hip fracture patients study: a retrospective study	21
Clinical impact of an individualised clinical pharmacy programme into the memory care pathway of older people: an observational study	20
Ethical conflicts in patient care situations of community pharmacists: a cross-sectional online survey	20

Fluoropyridmidine use and hypertriglyceridemia among Japanese patients: analysis of adverse event database	20
Anti‑CGRP monoclonal antibodies in resistant migraine: preliminary real-world effectiveness and clinical predictors of response at two years	20
Environmental scan of current strategies to decrease sedative-hypnotic drug use and promote sleep in hospital patients	19
Comparing patient reported and medical record data of adverse drug reactions to anti-seizure drugs	19
Real-world data of atezolizumab in patients with previously treated locally advanced or metastatic urothelial bladder cancer	19
Correction to: 49th ESCP virtual symposium on clinical pharmacy 19.10.2021–21.10.2021 Clinical pharmacy, working collaboratively in mental health care	18
Medication errors in emergency departments: a systematic review and meta-analysis of prevalence and severity	18
Correlation between the prognostic nutritional index and outcomes in older patients aged ≥ 60 years with chronic heart failure	18
Reliability and validity testing of the medicines related - consultation assessment tool for assessing pharmacists’ consultations	18
The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta-analysis	18
Developing a machine learning model for predicting venlafaxine active moiety concentration: a retrospective study using real-world evidence	17
Novel opportunities for clinical pharmacy research: development of a machine learning model to identify medication related causes of delirium in different patient groups	16
Exploring pharmacist involvement in the discharge medicines reconciliation process and information transfer to primary care: an observational study	16
Barriers to person-centered service design in pharmacy practice: examples, lessons, and potential solutions	15
Association of opioid fills with centers for disease control and prevention opioid guidelines and payer coverage policies: physician, insurance and geographic factors	15
Discrepancies in patients' medication lists from pharmacies in Sweden: an interview study before the implementation of the Swedish National Medication List	14
Critical care pharmacy service provision and workforce in adult extracorporeal membrane oxygenation centres: a multicentre cross-sectional survey	14
Liver injury associated with endothelin receptor antagonists: a pharmacovigilance study based on FDA adverse event reporting system data	14
Consumer views on the use of digital tools for reporting adverse drug reactions: a cross-sectional study	14
An umbrella review of the diagnostic value of next-generation sequencing in infectious diseases	14
A case–control study on the clinical characteristics of granisetron-related arrhythmias and the development of a predictive nomogram	14
Prolonged oxycodone use and potential risk factors in postoperative patients: a case control study	13
Appropriateness of intravenous fluid prescriptions in hospitalised patients: a point prevalence study	13
Assessing safety concerns of interstitial lung disease associated with antibody-drug conjugates: a real-world pharmacovigilance evaluation of the FDA adverse event reporting system	13
Translation and validation of the CLEO tool in Vietnamese to assess the significance of pharmacist interventions	13
Adherence to endocrine therapy in patients with hormone receptor-positive early-stage breast cancer: a retrospective study	13
Comparison of various basal insulin dose adjustments for inpatients while unable to eat	13
Medication supply at hospital discharge via community pharmacy: a quality improvement study	12
Evaluation of osimertinib for advanced non-small cell lung cancer with leptomeningeal metastases: a cost-effectiveness and budget impact analysis	12
Clinical pharmacists in Dutch general practice: an integrated care model to provide optimal pharmaceutical care	12
Pharmacist-led deprescribing of cardiovascular and diabetes medication within a clinical medication review: the LeMON study (Less Medicines in Older Patients in the Netherlands), a cluster randomized	12
How to write a successful grant application: guidance provided by the European Society of Clinical Pharmacy	12
How to manage the dose of drugs in cancer patients with acute kidney injury, practical recommendations	12
Potentially inappropriate prescribing in a falls clinic using the STOPP and START criteria	11
Cardiometabolic risk in people under 40 years with severe mental illness: reading between the guidelines	11
Economic evaluation of camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma in the United States and China	11
Anticholinergic burden and health-related quality of life among adult patients in a resource-limited setting: a cross-sectional study	11
Correction to: 50th ESCP Symposium on Clinical Pharmacy, Polypharmacy and ageing - highly individualized, interprofessional, person-centered care	11
Impact of a clinical pharmacist on medication safety in mental health Hospital-in-the-Home: a retrospective analysis	11
Complementary and alternative medicine use in self-management of diabetes: A qualitative study of patient and user conversations in online forums	11
Comment on “Association of polypharmacy with clinical outcomes and healthcare utilization in older adults with cardiometabolic diseases: a retrospective cohort study”	11
Valproic acid for agitation in the intensive care unit: an observational study of psychiatric consults	11
Cost-effectiveness of toripalimab plus chemotherapy for advanced esophageal squamous cell carcinoma	11
Risk factors for opioid toxicity requiring naloxone rescue in adults: a case-control study	11
What do emergency department pharmacist practitioners know and understand about patient safeguarding? A qualitative study	11
Embedding cultural competency and cultural humility in undergraduate pharmacist initial education and training: a qualitative exploration of pharmacy student perspectives	11
Cost-effectiveness of miglustat versus symptomatic therapy of Niemann–Pick disease type C	10
Prevalence and trends in polypharmacy and excessive polypharmacy: a retrospective national database analysis (2012–2021)	10
Opinions and experiences on the provision of care to people with mental illnesses: a qualitative study with Doctor of Pharmacy graduates after a rotation in psychiatry	10
Pharmacist-driven antimicrobial stewardship interventions in patients with COVID-19: a scoping review	10

Predicting delirium in older non-intensive care unit inpatients: development and validation of the DELIrium risK Tool (DELIKT)	10
Application of a screening tool to understand the medication habits of patients with swallowing difficulty: a prospective observational study	10
Pharmacists’ involvement in COVID-19 vaccination across Europe: a situational analysis of current practice and policy	9
Comment on “The efficacy of zuranolone versus placebo in postpartum depression and major depressive disorder: a systematic review and meta-analysis”	9
Identification of factors for a successful implementation of medication reviews in community pharmacies: Using Positive Deviance in pharmaceutical care	9
Drivers of engagement in virtual communities of practice: a qualitative study of Australian pharmacists’ perceptions and experiences	9
Preliminary feasibility assessment of a targeted, pharmacist-led intervention for older adults with polypharmacy: a mixed-methods study	9
Development of innovative simulation teaching for advanced general practice clinical pharmacists	9
Artificial intelligence in academic writing and clinical pharmacy education: consequences and opportunities	9
A consolidated framework for implementation research (CFIR) guided exploration of key informant perspectives on establishing a pharmacist-led anticoagulation service in primary care: a qualitative stu	9
Exploring the suitability of a ward-based clinical pharmacy activity collection tool for ambulatory care practice: a mixed-methods study	9
Addressing the second victim phenomenon among community pharmacists and its impact on clinical pharmacy practice: a consensus study	9
Potential drug-drug interactions of immunosuppressants in kidney transplant recipients: comparison of drug interaction resources	8
Prescribing at 95 years of age: cross-sectional findings from the Newcastle 85+ study	8
Communication issues between pharmacists and d/Deaf people: a qualitative study in Thailand	8
Barriers and facilitators to reducing anticholinergic burden: a qualitative systematic review	8
Cost-effectiveness of clobazam as an adjunctive treatment for refractory epilepsy in China	8
A cost–benefit analysis of hospital-wide medication reviews: a period prevalence study	8
Classification of patient characteristics associated with reported adverse drug events to neuraminidase inhibitors: an applicability study of latent class analysis in pharmacovigilance	8
Clinical Pharmacist and Clinical Nurse Specialist led medicine optimisation and medication adherence via eArly identifiCation advanCed gEriatric aSsesSment (ACCESS) tool in Senior Adult Oncology Progr	8
A quality improvement study on the effect of electronic transmission of a basic discharge medication report on medication discrepancies in patients discharged from the hospital	8
Real-world safety of maribavir: a retrospective study based on signal detection in the FDA adverse event reporting system	8
A retrospective cohort study of the effect of rapid versus delayed-result procalcitonin testing on antibiotic use at a community hospital	8
How patient-centredness takes place in pharmacy encounters: a critical common-sense interpretation of video-recorded meetings	8
Factors associated with Turkish pharmacists’ intention to receive COVID-19 vaccine: an observational study	8
SGLT2 inhibitors associated pancreatitis: signal identification through disproportionality analysis of spontaneous reports and review of case reports	8
Building an effective medicines optimisation model: a health system approach	8
Impact of artificial intelligence on the academic performance and test anxiety of pharmacy students in objective structured clinical examination: a randomized controlled trial	8
Exploring the time required by pharmacists to prepare discharge medicine lists: a time-and-motion study	8
Barriers and facilitators for the implementation of the CombiConsultation by general practitioners, pharmacists and practice nurses: a qualitative interview study	8
Correction: The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta‑analysis	7
Cost-effectiveness analysis of tislelizumab plus chemotherapy versus standard chemotherapy in first-line treatment for extensive-stage small cell lung cancer: perspectives from the United States and C	7
Association between sodium-glucose cotransporter 2 inhibitors and cancer: a systematic review and meta-analysis of randomized active-controlled trials	7
A randomised, crossover trial exploring the patient perspective and effectiveness of biosimilar adalimumab transition: IBD reference and biosimilar adalimumab cross over study (iBaSS)	7
Development of a robust predictive model for neutropenia after esophageal cancer chemotherapy using GLMMLasso	7
Investigating the controversy surrounding statin therapy and Achilles tendinopathy using Mendelian randomization analysis	7
Sex differences among users of NSAIDs and opioids during COVID-19 Pandemic	7
Medication changes and potentially inappropriate prescribing in older patients with significant polypharmacy	7
European Society of Clinical Pharmacy: ‘Implementing and scaling sustainable clinical pharmacy’	7
Between what is and what could be: a survey of pharmacists’ practices, attitudes, and beliefs in the provision of mental health care	7
Assessing the cost-effectiveness of replacing antimetabolites with mTOR inhibitors in heart transplant immunosuppression in China: a network meta-analysis-based economic evaluation	7
Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study	7
Patient and hospital staff perspectives on introducing pharmacist-led medication reviews at an orthopedic ward: a mixed methods pilot study	7
Comparison of the incidence of nausea and vomiting between linezolid and vancomycin using claims database: a retrospective cohort study	7
Pharmacist-led new medicine service: a real-world cohort study in the Netherlands on drug-related problems, satisfaction, and self-efficacy in cardiovascular patients transitioning to primary care	7
Antimicrobial utilization and resistance in Pseudomonas aeruginosa using segmented regression analysis: a comparative study between Serbia and eight European Countries	7
Discrepancies among equations to estimate the glomerular filtration rate for drug dosing decision making in aged patients: a cross sectional study	7
Risk factors for potentially inappropriate medication use in older adults: a cohort study	7
Implementation of pharmacist-led deprescribing in collaborative primary care settings	7
Sex differences in immune-related adverse events with immune checkpoint inhibitors: data mining of the FDA adverse event reporting system	7
Economic cost-benefit analysis of person-centred medicines reviews by general practice pharmacists	7
Polypharmacy and medication regimen complexity in transfusion-dependent thalassaemia patients: a cross- sectional study	7
A qualitative exploration of the enablers and barriers to the provision of outpatient clinics by hospital pharmacists	7
Development, implementation and evaluation of the digital transformation of renal services in Wales: the journey from local to national	6
Abstracts of the 26th Annual Meeting of ESPACOMP, the International Society for Medication Adherence, Berlin, Germany, 17–19 November 2022	6
Optimising adherence to secondary prevention medications following acute coronary syndrome utilising telehealth cardiology pharmacist clinics: a matched cohort study	6
Correction: Development and validation of a Medication Adherence Universal Questionnaire: the MAUQ	6
Provision of drug and alcohol services amidst COVID-19 pandemic: a qualitative evaluation on the experiences of service providers	6
Population- and individual-level trajectories of opioid prescription patterns among adults with cerebral palsy: a retrospective cohort study	6
Drug-related emergency department visits: external validation of an assessment tool in a general emergency department population	6
Feasibility of individualised patient modelling for continuous vancomycin infusions in outpatient antimicrobial therapy, a retrospective study	6
ESCP Spring Workshop 2023: Advancing clinical pharmacy and care in diabetes and cardiovascular comorbidities—Antwerp, 20–21 April 2023	6
Scope, content and quality of clinical pharmacy practice guidelines: a systematic review	6
Polypharmacy and medication regimen complexity in older patients with hemophilia or von willebrand disease: the M’HEMORRH-AGE study	6
Levels of serum lipids predict responses to PD-L1 inhibitors as first-line treatment in small cell lung cancer: an observational study	6
Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database	6
Determining sensitivity and specificity of risk scores for QTc interval prolongation in hemato-oncology patients prescribed systemic antifungal therapy: a retrospective cross-sectional study	6
Terms used to describe and define activities undertaken as a result of the medication review process: Do they require standardisation? A systematic review	6
Publisher Correction to: Bacillus coagulans TBC169 probiotics for the recovery of intestinal function after gynecological laparoscopic surgery: a randomized, placebo-controlled trial	6
Accuracy of best possible medication histories by pharmacy students: an observational study	6
Delabeling of allergy to beta-lactam antibiotics in hospitalized patients: a prospective study evaluating cost savings	6
Correction: Credentialed pharmacist-led home medicines reviews targeting treatable traits and their impact on health outcomes in people with chronic obstructive pulmonary disease: a pre- and post-inte	6
Short-term outcome of personalized theory-based pharmaceutical care service on the medication administration problems of family caregivers: a pre-post intervention study	6
Remdesivir for COVID-19 and acute kidney injury: disproportionality analysis of data from the U.S. Food and Drug Administration Adverse Event Reporting System	6
An assessment of the reporting of tapering methods in antidepressant discontinuation trials using the TIDieR checklist	5
Consensus on the criteria for patient prioritization in hospital clinical pharmacy services: a Delphi study	5
Community pharmacists’ acceptability of pharmacist-delivered depression screening for older adults: a qualitative study	5
Influence of a ward-based pharmacist on the medication quality of geriatric inpatients: a before–after study	5
Author Correction: Assessing safety concerns of interstitial lung disease associated with antibody-drug conjugates: a real-world pharmacovigilance evaluation of the FDA adverse event reporting system	5
Association of silodosin, tamsulosin, and naftopidil with delirium: analysis of the pharmacovigilance database in Japan	5

Timeliness of administration of amoxicillin-clavulanic acid and meropenem in a large tertiary care centre	5
Improving medication adherence in the community: a purposive umbrella review of effective patient-directed interventions that are readily implementable in the United Kingdom National Health Service	5
European Society of Clinical Pharmacy definition of the term clinical pharmacy and its relationship to pharmaceutical care: a position paper	5
Co-designing psychosis simulated patient scenarios with mental health stakeholders for pharmacy curricula	5
Comparison of clinical effectiveness of conbercept and ranibizumab for treating retinopathy of prematurity: a meta-analysis	5
Commentary: how person-centred is pharmaceutical care?	5
A cohort study of guselkumab in the treatment of psoriasis refractory to previous biologic therapies: effectiveness, safety and adherence	5
Associated factors and safety of the rapidly achieving first therapeutic target of warfarin in hospitalized patients: a retrospective cohort study	5
Accuracy in patient-reported adverse drug reactions and their recognition: a mixed-methods study	5
Exploring the impact of baseline platelet count on linezolid-induced thrombocytopenia: a retrospective single-center observation study	5
Medicines-related interventions to support safe transitions for care home residents post hospital discharge: Do hospital-delivered interventions have a role?	5
Exploring patients’ pharmacy stories: an analysis of online feedback	5
Thank you from the Editor-in-Chief	5
Developing a theory-based behavior change intervention to improve the prescription of surgical prophylaxis	5
Opioid, sedative, preadmission medication and iatrogenic withdrawal risk in UK adult critically ill patients: a point prevalence study	5
Effectiveness of a structured pharmacist-delivered intervention for patients post-acute coronary syndromes on all-cause hospitalizations and cardiac-related hospital readmissions: a prospective quasi-	5
Glucagon-like peptide 1 receptor agonists and the potential risk of pancreatic carcinoma: a pharmacovigilance study using the FDA Adverse Event Reporting System and literature visualization analysis	5
“A little bit more looking…listening and feeling” A qualitative interview study exploring advanced clinical practice in primary care and community pharmacy	5
Application of behavioural theories, models, and frameworks in pharmacy practice research based on published evidence: a scoping review	5
Flight safety risk assessment of self-medication among fighter pilots: a cross-sectional study	5
A qualitative exploration of the impact of a hospital electronic prescribing and medicines administration (HEPMA) protocol on junior doctor confidence and competence to prescribe end-of-life care medi	5
Group based trajectory modeling to assess adherence to oral anticoagulants among atrial fibrillation patients with comorbidities: a retrospective study	5
Developing a machine learning-based predictive model for the analgesic effectiveness of transdermal fentanyl in cancer patients: an interpretable approach	5
Effect of duloxetine on pain and opioid consumption after total knee and hip arthroplasty: a systematic review and meta-analysis of randomized controlled trials	5
A qualitative exploration of the healthcare challenges and pharmaceutical care needs of people with Parkinson’s and their caregivers	5
Evaluating the impact of PD-1 inhibitor treatment on key health outcomes for cancer patients in China	5